ARANX | CRDRX | ARANX / CRDRX | |
Total Expense Ratio | 1.28 | 0.82 | 156% |
Annual Report Gross Expense Ratio | 1.28 | 0.82 | 156% |
Fund Existence | 11 years | 13 years | - |
Gain YTD | 11.449 | 12.644 | 91% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.4B | 2.5B | 56% |
Annual Yield % from dividends | 0.48 | 2.24 | 21% |
Returns for 1 year | -1.06 | 10.29 | -10% |
Returns for 3 years | 35.74 | 34.65 | 103% |
Returns for 5 years | 33.14 | 11.60 | 286% |
Returns for 10 years | 47.63 | 36.61 | 130% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DTCCX | 15.95 | 0.08 | +0.50% |
BNY Mellon Sust US Equity C | |||
FGRCX | 28.84 | 0.13 | +0.45% |
Fidelity Advisor Mega Cap Stock C | |||
ETIHX | 43.18 | 0.06 | +0.14% |
Eventide Healthcare & Life Sciences I | |||
ASQAX | 16.67 | -0.04 | -0.24% |
American Century Small Company A | |||
WICGX | 6.51 | -0.17 | -2.54% |
William Blair China Growth I |